TCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study December 26, 2014
TCL Archive Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate March 25, 2011
TCL Archive Bush Signs HHS Appropriations; NCI Budget $4.188B After Administrative Rescission. January 11, 2002
TCL Archive Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned March 17, 1995
